S&P 500
(0.05%) 5 251.02 points
Dow J
(0.05%) 39 781 points
Nasdaq
(-0.12%) 16 379 points
Oil
(1.59%) $82.64
Gas
(0.58%) $1.728
Gold
(1.00%) $2 234.90
Silver
(0.48%) $24.87
Platinum
(1.34%) $921.85
USD/EUR
(0.28%) $0.926
USD/NOK
(0.69%) $10.84
USD/GBP
(0.02%) $0.791
USD/RUB
(0.17%) $92.60

Realtime updates for Biotron Ltd [BIT.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 00:39

2.53% $ 0.0810

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 00:39):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Biotron Ltd

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia...

Stats
Today's Volume 1.18M
Average Volume 1.65M
Market Cap 70.34M
EPS $0 ( 2024-02-27 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -8.10
ATR14 $0.00100 (1.23%)

Volume Correlation

Long: 0.22 (neutral)
Short: 0.85 (strong)
Signal:(62.004) Same movement expected

Biotron Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biotron Ltd Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag -0.54
( weak negative )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.29
( neutral )

Biotron Ltd Financials

Annual 2023
Revenue: $1.43M
Gross Profit: $1.39M (96.97 %)
EPS: $-0.00430
Q2 2023
Revenue: $0
Gross Profit: $-21 702.00 (0.00 %)
EPS: $-0.00150
Q4 2023
Revenue: $0
Gross Profit: $-20 828.00 (0.00 %)
EPS: $-0.00300
Q3 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.00150

Financial Reports:

No articles found.

Biotron Ltd

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators